Akèy › Maladi dejeneratif nè › Florid › Orlando

Etid klinik pou Maladi dejeneratif nè nan Orlando, FL

5 etid pou Maladi dejeneratif nè ap chèche patisipan nan sit nan ak bò kote Orlando (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis

Ap rekriteFaz 2

Clinical Site, Orlando

Laj 55 a 90 · Tout sèks · Mizajou Sep 30, 2026 · NCT06887192

A Study of LY3439539 in Participants With Alzheimer's Disease

Ap rekriteFaz 1

Charter Research, Orlando
AdventHealth Orlando, Orlando
K2 Medical Research, Maitland · 6 mi lwen

Laj 50 a 85 · Tout sèks · Mizajou Sep 24, 2026 · NCT07598370

A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)

Ap rekriteFaz 2

Charter Research - Orlando, Orlando
Conquest Research, Winter Park · 5 mi lwen
K2 Medical Research ORLANDO, Maitland · 6 mi lwen

Laj 55 a 85 · Tout sèks · Mizajou Sep 22, 2026 · NCT07589595

A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic Therapy

Ap rekriteFaz 2

Vima Site #065, Altamonte Springs · 9 mi lwen

Laj 18 a 65 · Tout sèks · Mizajou Sep 11, 2026 · NCT07804615

A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's Disease

Ap rekriteFaz 1

K2 Medical Research, LLC, Maitland · 6 mi lwen

Laj 50 a 85 · Tout sèks · Mizajou Aug 24, 2026 · NCT06297590

Etid Maladi dejeneratif nè nan lòt vil

Lòt etid nan Orlando

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.